drugIndia
Cart
Glytas M 30mg/500mg Tablet ER

Glytas M 30mg/500mg Tablet ER

Gliclazide (30mg) + Metformin (500mg)

Tas Med India Pvt Ltd
Gynae
92.00115.0020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 26%
Best Alternative100% Match

Glychek-M OD 30mg/500mg Tablet

Indoco Remedies Ltd

Gliclazide 30mg
Glychek-M OD 30mg/500mg Tablet

Pack Size

1 units

Price

68.4820% off
Glychek-M OD 30mg/500mg Tablet is 100% same as Glytas M 30mg/500mg Tablet ER
Better ValueSame QualitySame Effectiveness

Save ₹24

that's 26% off!

composition
  1. Gliclazide 30mg
  2. Metformin 500mg
Buy Now
92.0020% OFF
115.00

About This Medicine

Product description & overview

Glytas M 30mg/500mg Tablet ER: Long-lasting Blood Sugar Control

Glytas M 30mg/500mg is a once-daily extended-release tablet specifically formulated to manage both Type 2 diabetes. It combines the potent hypoglycemic effects of Gliclazide (30mg) with the broad spectrum efficacy of Metformin (500mg).

These ingredients work synergistically to:

* Lower blood sugar: Gliclazide helps insulin release, while Metformin directly reduces glucose production and absorption.
* Promote glucose utilization: This combination allows for improved blood glucose control.
* Improve glycemic variability: The extended-release formula ensures consistent, long-lasting effects throughout the day.

Glytas M 30mg/500mg is ideal for patients seeking:

* Simplified dosing: One daily tablet simplifies medication adherence.
* Enhanced efficacy: The combined action of Gliclazide and Metformin delivers optimal control.

Always consult your healthcare provider for proper diagnosis and treatment.

Active composition

Gliclazide 30 mg

+1 more active ingredient

About Gliclazide

Gliclazide is an oral hypoglycemic agent used to treat type 2 diabetes mellitus. It works by stimulating insulin release from the pancreas, thereby lowering blood sugar levels. Gliclazide is effective in managing diabetes and preventing complications associated with high blood sugar. Common side effects may include nausea and stomach discomfort, but these usually resolve over time. In summary, Gliclazide is important for controlling blood sugar levels in diabetic patients.

How It Works

Gliclazide stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues.

Medicine Strength
30 mg

All Active Ingredients

Gliclazide30 mg
Metformin500 mg

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glytas M 30mg/500mg Tablet ER.

High Risk

Pregnancy

Glytas M 30mg/500mg Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glytas M 30mg/500mg Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glytas M 30mg/500mg Tablet ER may be needed. Please consult your doctor. Glytas M 30mg/500mg Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glytas M 30mg/500mg Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glytas M 30mg/500mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glytas M 30mg/500mg Tablet ER may be needed. Please consult your doctor. Use of Glytas M 30mg/500mg Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Regular Checkup

Customer Reviews

0 reviews for Glytas M 30mg/500mg Tablet ER

Products matching your search